Group 1 - The Hong Kong Innovative Drug ETF (159567) experienced a decline of 2.05% with a trading volume of 846 million yuan on December 29 [1] - The fund's shares increased by 29 million to a total of 10.496 billion shares, with a total increase of 610 million shares over the past 20 trading days [1] - The latest net asset value of the fund is calculated to be 8.05 billion yuan [1] Group 2 - The performance benchmark for the Hong Kong Innovative Drug ETF is the National Index of Hong Kong Innovative Drugs, adjusted for valuation exchange rates [1] - The fund is managed by Yinhua Fund Management Co., Ltd., with the fund manager being Ma Jun [1] - Since its establishment on January 3, 2024, the fund has achieved a return of 53.40%, while the return over the past month is -10.82% [1]
12月29日港股创新药ETF（159567）份额增加2900.00万份
Xin Lang Cai Jing·2025-12-30 01:10